Could, Invest, I am wondering too if any of our regulatory bodies could come out with something like the EMA where they stated that EPA and DHA mixtures are not effective or recommended (not sure if they have stopped the sale of them or not) for CVD treatment. Although still approved for hypertriglyceridemia. By the number scripts written for GL we know that many are for CVD and not just trigs over 500.
No question like you say there are many things big pharma could have done a multitude of times better than Amarin when it comes to V. Unfortunately management and the courts have screw us out of the US component. They better sell the company before they have a chance to piss away the EU.
Market Data 
Markets 
AI
